GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Upbeat corporate guidances lift European shares, Nvidia forecast boosts chip stocks

Thu, 23rd Feb 2023 17:22

UK healthcare giants fall on ex-dividend trades

*

WPP leads gains among media stocks

*

AXA rises on guidance hike, surprise share buy-back

*

Rolls-Royce jumps on upbeat profit outlook for 2023

*

Euro zone inflation marginally higher in Jan; core also lifted

*

STOXX 600 up 0.1%

Feb 23 (Reuters) - European shares inched higher on Thursday, after two straight sessions of declines, supported by financial stocks and upbeat guidance by regional companies, while U.S. semiconductor designer Nvidia's positive sales forecast sparked a rally in chip stocks.

The pan-European STOXX 600 index rose 0.1%.

AXA

rose 3.2% after the French insurer raised its 2023 guidance and announced a share buy-back programme, while posting lower-than-expected full-year earnings.

Banks gained 0.9%, while insurers added 0.3%.

Also aiding sentiment, data earlier in the day showed that euro zone inflation was only a

touch higher

than earlier estimated in January, confirming that price growth is now well past its peak.

The rate-sensitive technology sector rose 0.4%, supported by a jump in semiconductor stocks.

Chipmakers ASM International, BE Semiconductor and Aixtron gained between 0.4% and 1.2%.

U.S. peer Nvidia Corp forecast first-quarter revenue above Wall Street estimates on Wednesday, noting a strong boost from the use of its chips in artificial intelligence (AI) services such as chatbots.

The shorter-term demand for chips will get a boost to fuel "an AI gold rush, if you think such a phenomenon will actually materialize," said Greg Bassuk, chief executive at AXS Investments.

However, the worries of central banks raising interest rates for longer still lingered.

The minutes from the U.S. Federal Reserve's last policy meeting released on Wednesday showed nearly all policymakers rallied behind a decision to further slow the pace of interest rate hikes, noting inflation would determine how much further rates needed to rise.

"The starkest takeaway was, arguably, that some policymakers could have gotten behind another 50 basis point increase and all backed further tightening ahead," said Craig Erlam, senior market analyst at OANDA.

Recent data showed French and German economic activity moved into growth territory, while a rebound in U.S. business activity also backed views that interest rates in both economies will remain higher for longer.

Still, the STOXX 600 has risen nearly 9% so far this year, more than double the S&P 500 index's 3.9% rise.

Europe has benefited from better weather, hopes that the economy will narrowly avoid a recession and a boost from China's reopening.

Engineering firm Rolls-Royce surged 23.7%, to the top of the STOXX 600, after the company's CEO forecast more profit growth in 2023 after last year's profit beat expectations.

Auto stocks rose 1.0%, with carmaker Stellantis up 3.6%.

Media stocks were up 0.3%, boosted by a 3.4% rise in British ad group WPP after it forecast better-than-expected organic growth of 3% to 5% for the year.

UK banks and healthcare majors fell, weighing on the FTSE 100 index. Barclays, Standard Chartered , AstraZeneca and GSK fell as they traded without an entitlement for dividend payout. (Reporting by Shreyashi Sanyal in Bengaluru; Editing by Subhranshu Sahu, Savio D'Souza and Andrew Heavens)

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.